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G protein-coupled receptors (GPCRs) respond to
agonists to activate downstream enzymatic path-
ways or to gate ion channel function. Turning off
GPCR signaling is known to involve phosphorylation
of the GPCR by GPCR kinases (GRKs) to initiate their
internalization. The process, however, is relatively
slow and cannot account for the faster desensitiza-
tion responses required to regulate channel gating.
Here, we show that GRKs enable rapid desensitiza-
tion of the G protein-coupled potassium channel
(GIRK/Kir3.x) through a mechanism independent of
their kinase activity. On GPCR activation, GRKs
translocate to the membrane and quench channel
activation by competitively binding and titrating G
protein bg subunits away from the channel. Of
interest, the ability of GRKs to effect this rapid desen-
sitization depends on the receptor type. The findings
thus reveal a stimulus-specific, phosphorylation-
independent mechanism for rapidly downregulating
GPCR activity at the effector level.INTRODUCTION
G protein-coupled receptors (GPCR) modulate the activity of
enzymes and ion channels to fine tune cellular activity (Pierce
et al., 2002). To avoid abnormal cellular activity, GPCR-mediated
G protein cycles should be temporally precise. Several mecha-
nisms guarantee the precise length of GPCR activation by
controlling the levels of agonist. For example, the level of free
neurotransmitters present in the synapse are limited by fast
neurotransmitter reuptake at the presynaptic site (Torres et al.,
2003), or degradation at the synaptic cleft (Massoulie et al.,
1993). These processes are specific for specific types of ligands.
For regulation at a longer time scale, additional mechanisms
control GPCR signaling efficacy. These mechanisms control
the robustness of the activation signals by regulating receptor
number at the plasma membrane, in a process termed downre-
gulation (Bunemann et al., 1999; Tsao and von Zastrow, 2000).
This mechanism involves a receptor-mediated signaling750 Cell 143, 750–760, November 24, 2010 ª2010 Elsevier Inc.cascade, where activated receptors are initially phosphorylated
by GPCR kinases (GRKs), to initiate intracellular events leading
to a clathrin-mediated endocytosis of the GPCRs. This process
occurs over a time scale of many minutes to hours.
In the context of GPCR-mediated regulation of ion channel
activity, short-term desensitization to an activating signal has
been observed. For instance, regulation of GPCR-controlled
excitability through the activation of the G protein-coupled
potassium channels (GIRK/Kir3.x), displays short-term desensi-
tization characterized by a reduction in channel currents in the
presence of the receptor agonist in a time scale of few seconds
(Sickmann and Alzheimer, 2003). This short-term reduction in
postsynaptic GIRK channel activity is independent of elements
that are known to affect the G protein cycle and PtdIns(4,5)P2
hydrolysis. It is, therefore, of great interest to identify the molec-
ular mechanism that mediates this process.
We set out to identify the mechanism responsible for short-
term desensitization of GIRK channels. We found that for some
GPCRs, continued activation of their receptors leads to GIRK
current desensitization (GCD). This current desensitization is
enhanced in the presence of GRK2 and, surprisingly, does not
involve its kinase activity, but rather depends on its ability to
bind the Gbg subunits of the G protein. This binding appears
to compete for the available pool of the G protein subunits that
activate the channel and hence to effectively quench channel
activity. These findings assign a new role for the GRK proteins
in providing negative feedback control of GPCR function at the
effector level.RESULTS
GRK2 Accelerates Desensitization of GIRK Currents
Induced by A1R and mOR, but Not by mGluR2 and M4R
We set out to test the involvement of GRK2 in mediating short-
term desensitization of GIRK channels. GRK2 is involved in the
desensitization of GPCRs after exposure to their agonists. For
this purpose we expressed GIRK1, GIRK4 (for now on referred
as GIRK channels) and adenosine type 1 receptor (A1R) with or
without (control) GRK2 in HEK293 cells, and used whole cell
patch-clamp recordings to measure various channel current
parameters after receptor activation by adenosine (Figure 1A).
After A1R activation by adenosine (100 mM), GIRK channel
currents desensitize (GCD) as evident from themonoexponential
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Figure 1. GRK2 Accelerates the Desensiti-
zation of GIRK Currents Induced by A1R,
but Not by mGluR2
(A) GIRK channel currents induced by the activa-
tion of A1R rapidly desensitize in the presence of
GRK2.
(B) GIRK channel currents induced by mGluR2
activation are insensitive to GRK2.
(C) Bar plot that depicts GCD rates of cells acti-
vated with A1R or mGluR2 without or with GRK2,
GRK2 shRNA, or nontarget (NT) shRNA.
(D) Bar plot compares the normalized expression
levels of GRK2 in silenced and NT cells as de-
picted from western blot for GRK2 (inset).
(E) GIRK current traces induced by adenosine in
control HL-1 cell (black) and of siRNA#1 silenced
cell (gray).
(F) Bar plot depicting GCD in HL-1 cells trans-
fected with two independent siRNAs, NT, and
siRNA#1 transfected cells rescued by the expres-
sion of silently mutated GRK2GFP (smGRK2GFP).
(G) GRK2 mRNA quantification in HL-1 cells trans-
fected with two independent siRNAs or NT control.
See also Figure S1.decay curve of the current traces with a time constant of 24.9 ±
11.1 s, n = 8 (Figures 1A, upper trace, and 1C). Interestingly, in
cells cotransfected with GRK2, GCD rates were accelerated
10-fold, to 2.6 ± 0.0 s, n = 9 (p < 0.05). To assess whether
the enhancement of current desensitization was a general
phenomena to all PTX-sensitive GPCRs, we also tested GCD
rates induced by m-opioid receptor (mOR). Similar to the effect
of GRK2 on A1R-mediated GCD, mOR activation (methionine
enkephalin, ME, 100 nM) accelerated GCD in the presence of
GRK2 compared to control cells, with a time constant of 38.9 ±
5.9 s, n = 10 and 64.4 ± 6.18 s, n = 7, respectively (see Figures
S1A and S1C available online). In contrast, activation of GIRK
channels in the absence or presence of GRK2 by metabotropic
glutamate type 2 receptor (mGluR2) (Figures 1B and 1C) or
muscarinic acetylcholine type 4 receptor (M4R) activation
(Figures S1B and S1C) did not show any acceleration in GCD,
with time constants 41.7 ± 8.6 s, n = 9 and 41.7 ± 9.5 s, n = 9,Cell 143, 750–760, Nrespectively for mGluR2, and 37.7 ±
10.7 s, n = 7 and 33.4 ± 11.7 s, n = 6,
respectively, for M4R. Like in the case
shown above for GRK2, GRK3, but not
GRK6, also accelerated GCD in a similar
receptor-specific manner (data not
shown).
Because GRK2 is endogenously ex-
pressed in HEK293 cells (Violin et al.,
2006), we were interested to know
whether there is a contribution of the
endogenous protein to current desensiti-
zation in cells not transfected with GRK2.
To address this question we silenced
endogenous GRK2 levels using shRNA
specific for the human GRK2 (shGRK2).
GRK2 expression levels were reducedby 58%, as determined using western blot (Figure 1D). A1R-in-
duced GIRK currents were significantly slower in GRK2-silenced
cells (42.9 ± 6.8 s, n = 12) in comparison with cells cotransfected
with nontarget (NT) shRNA (26.0 ± 4.5 s, n = 12) (Figure 1C), con-
firming that endogenous levels of GRK2 are sufficient to enhance
GCD rate after A1R simulation. The above results suggest that
GRK2 has a role in modulating current desensitization rates of
GIRK currents in a receptor-selective manner.
To study whether GRK is also involved in GCD in cells that
natively express GIRK, A1R and the kinase, we measured
GIRK currents in HL-1 cells. HL-1 is a mouse cardiac muscle
cell-line that maintains the characteristics of adult cardiac myo-
cytes, including contraction (Claycomb et al., 1998). These cells
express both GIRK channels and the necessary components for
their activation (Nobles et al., 2010). GIRK currents of HL-1 cells,
where GRK2 was silenced using two independent siRNAs,
(siGRK2#1 and siGRK2#2) displayed significantly smallerovember 24, 2010 ª2010 Elsevier Inc. 751
desensitizations compared to cells transfected with NT (Figures
1E and 1F). After continuous application of adenosine, the
induced currents were reduced to 79.2 ± 11.0% (n = 6), 86.3 ±
7.3% (n = 5) and 24.7 ± 7.4% (n = 6) at 2 min, for both silenced
and NT cells, respectively. Expression of silently mutated
GRK2-GFP (smGRK2-GFP) in cells silenced with siGRK2#1
rescued the reduction in current desensitization (31.5 ± 12.5%,
n = 4) to levels comparable to NT cells (Figure 1F). Similarly,
GRK2 mRNA levels were reduced in cells transfected with either
siGRK2#1 or siGRK2#2 compared to NT control cells with 54.0 ±
2.4% and 57.1 ± 0.6%, respectively (Figure 1G). Qualitatively
similar results were obtained using primary mouse hippocampal
neurons (Figure S1). These experiments suggest that, qualita-
tively, the effect of GRK in HEK cells is relevant at physiological
expression levels, and is not due to overexpression of GRK, the
receptors or the channels.
A1R Activation Recruits GRK2-GFP to the Membrane
Simultaneously with GIRK Current Desensitization,
but Not mGluR2
GRK2 is mainly cytosolic and translocates to the membrane to
phosphorylate active receptors (Pitcher et al., 1998). We wanted
to detect these translocations and to test whether there is a
correlation between the acceleration of GIRK desensitization
rates and GRK translocations. For this purpose, we C-terminally
tagged GRK2 with EGFP (GRK2-GFP) and used total internal
reflection fluorescence (TIRF) microscopy to detect exclusively
the membrane-associated fluorescence (Riven et al., 2003).
Cells transfected with GRK2-GFP and A1R showed a significant
GRK2-GFP basal membrane associated fluorescence (Fig-
ure 2A), as previously reported (Garcia-Higuera et al., 1994).
On A1R activation (Figures 2B and 2C) the membrane-associ-
ated fluorescent signal increased by 22.2 ± 6.2% with a t of
1.5 ± 0.4 s (Figures 2D and 2F). mOR also increased membrane
associated fluorescence on activation by 10.8 ± 2.8% with a t
of 23.4 ± 3.9 s (n = 11), temporally correlated with GCD for this
receptor (Figure S1D). Similar to the inability of mGluR2 to
accelerate GCD, membrane associated fluorescence also did
not significantly increase after mGluR2 activation (Figure 2D).
Similarly, M4R activation by carbachol did not induce GRK2
translocation to the membrane (data not shown). The transloca-
tions of GRK2-GFP to the membrane were reversible, as
membrane fluorescence returned to its basal level after washing
out the agonist (Figure S2). These results may indicate a strong
correlation between GRK2 translocation to the plasma
membrane and the acceleration in GCD rates. To further
strengthen this idea, we recorded A1R induced GIRK currents
and measured GRK-GFP translocation simultaneously, using
whole cell recording of the patch clamp technique, and quantita-
tive fluorescence under TIRF, respectively (Figure 2E). In cells
measured this way, GIRK desensitization and GRK2 recruit-
ments to the membrane occurred simultaneously, with change
of currents andmembrane-associated fluorescence displaying t
of 2.4 ± 0.5 s and 4.6 ± 0.9 s, n = 5, respectively. Additional
independent observations of GCD rates and membrane-associ-
ated fluorescence increase of GRK2-GFP were also temporally
correlated with t of 1.3 ± 0.3 s, n = 20 and 1.5 ± 0.4 s, n = 11,
respectively (Figure 2F).752 Cell 143, 750–760, November 24, 2010 ª2010 Elsevier Inc.GPCR Phosphorylation and Receptor Downregulation
Are Not Required for GRK2-Mediated GIRK Current
Desensitization
In the traditional view, after translocation to the membrane,
GRKs are responsible for the phosphorylation of activated
GPCRs. This event initiates the process of receptor downregula-
tion by clathrin-mediated endocytosis (Tsao and von Zastrow,
2000). To examine the relationship between this process and
the apparent GRK2-mediated acceleration in GCD as shown
above, we tested the ability of GRK2/K220R (dnGRK2), a domi-
nant negative mutant that lacks kinase catalytic activity (Kong
et al., 1994), in accelerating GCD rates (Figure 3A). The GCD
rates of cell cotransfected with GIRK, A1R, and dnGRK2 (5.5 ±
1.1 s, n = 9) were not different from cells expressing GRK2, the
receptor and channel components, with t of 2.6 ± 0.0 s (n = 9),
and significantly faster than in cells that were not cotransfected
with the kinase (24.9 ± 11.1 s; n = 8). These results suggest that
the enhancement of GCD rates is not mediated via the kinase
activity of GRK2.
Another possible mechanism for enhancing GCD might be
a change in receptor number, independent of GRK2-mediated
phosphorylation, or channel number, at the plasma membrane.
To test for these two possibilities, we C-terminally tagged the
A1R with GFP (A1R-GFP) or C-terminally tagged GIRK4 with
GFP (GIRK4-GFP) andmeasured plasmamembrane-associated
fluorescence under TIRF. A1R-GFP and GIRK4-GFP plasma
membrane levels remained constant in the first minute after
agonist application both in control cells and in cells cotrans-
fected with GRK2, with DF/F of 96.3 ± 1.0%; n = 6 and 97.7 ±
0.3%; n = 12, for A1R-GFP and 96.4 ± 0.6%; n = 5 and
106.5 ± 1.4%; n = 9, for GIRK4-GFP, respectively (Figure 3B).
These results suggest that GRK2-mediated acceleration of the
GCD is neither due to a loss of receptors nor due to a loss of
GIRK channels from the plasma membrane.
Pertussis Toxin-Insensitive Pathways Are Sufficient
to Induce GRK2 Translocations and Acceleration
of GIRK Current Desensitization
The sensitivity of A1R and mOR to GRK2-mediated desensitiza-
tionwas distinct in comparison tomGluR2 andM4R,GPCRs that
display pure Gi/o activation. However, whereas A1R and mOR
primarily activate the Gi/o pathway, they may have also a
secondary transduction mechanism through different G protein
subsets (Cordeaux et al., 2004). We therefore tested whether
other minor secondary G protein activation mechanisms might
explain the selectivity of only a subset of receptors to induce
GRK2-mediated GCD. To inactivate the Gai/o pathway, we
coexpressed the catalytic subunit of pertussis toxin, PTX-S1,
that been shown to effectively abolish GPCR-mediated GIRK
activation (Sadja and Reuveny, 2009). In cells cotransfected
with PTX-S1, A1R, and GIRK channels, A1R activation did not
induce GIRK currents, in agreement with Gai/o sensitivity to
PTX (Figure 3C, middle). In contrast, when cells cotransfected
with both GRK2 and PTX-S1 were activated, the basal activity
of the GIRK channels, assessed by barium sensitivity of the
inward K+ currents at 80 mV, was rapidly reduced, in agree-
ment with the observation that amajor part of GIRK basal activity
is Gbg-dependent (Rishal et al., 2005). Along the same line,
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Figure 3. Kinase Catalytic Activity Is Not Required for GRK2 Effect
on GCD
A1R-GFP or GIRK1/GIRK4-GFP plasma membrane levels are not affected by
A1R stimulation. PTX treatment is not affecting basal GCD and membrane
recruitment.
(A) A bar graph summarizing measurements of GCD rates (t, s) from cells
cotransfected with GRK2/K220R (dnGRK2), GIRK, and A1R.
(B) The relative change of membrane fluorescence under TIRF (DF/F, %) asso-
ciated with either A1R-GFP or GIRK1/GIRK4-GFP before and during A1R
activation (1 min after adenosine application).
(C) Typical current traces of cells expressing GIRK and A1R (control); GIRK,
A1R and PTX (+PTX); and GIRK, A1R, PTX and GRK2 (+PTX +GRK2).
(D) A bar plot summarizing DF/F of GRK2-GFP signal after A1R activation,
measured under TIRF in cells expressing GIRK, PTX, and GRK2.
(E) A typical TIRF data of the membrane fluorescence change of GRK2-GFP
overtime of a cell expressing PTX after A1R activation.
See also Figure S3.
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Figure 2. A1R Activation Recruits GFP-Tagged GRK2 to the
Membrane Simultaneously with GCD as Revealed under TIRF
(A) A TIRF image of HEK293 cell transfected with GRK2-GFP. Basal membra-
nous fluorescence can be detected before stimulation by A1R.
(B) Image of the same cell in the presence of adenosine.
(C) Time course of fluorescence increase seen on receptor activation.
(D) A bar plot comparing the relative membrane-associated fluorescent
change (DF/F, in %) of GRK2-GFP after activation of A1R or mGluR2.
(E) Typical trace of whole-cell GIRK currents (black) and TIRF signal (green)
recorded simultaneously from the same cell.
(F) Bar graph depicting the similarity between GRK2-GFP translocation and
GCD rates.
See also Figure S2.GRK2 translocation to the plasma membrane remained intact,
demonstrating that GRK2 membrane recruitment is not depen-
dent on the Gai/o pathway (Figures 3D and 3E). DF/F values
without or with PTX were 7.8 ± 0.6%, n = 13 and 8.0 ± 1.0%,
n = 7, respectively. As shown above, PTX-insensitive pathways
were sufficient to induce GRK2 translocations. The involvement
of other G protein signaling pathways, Gaq and Gas, were also
tested and were found not to be involved in GRK2 action on
GCD (Figures S3).
The Effects of Mutations in GRK2 that Impair Its
Interaction with Various Auxiliary Molecules
GRK2 is known to form a quaternary complex with Gaq and Gbg
(Tesmer et al., 2005). We set out to test whether impairing its
ability to interact with these auxiliary proteins may affect theability of GRK2 to accelerate GCD rates. GRK2 mutations that
disrupt GRK2-Gaq interaction, GRK2/R106A;D110A (Day et al.,
2004; Sterne-Marr et al., 2003) were tested. These mutations
are located in the RGS homology domain that is known to bind
Gaq but not Gai/o (Carman et al., 1999). GRK2/R106A;D110A
also accelerated GCD, similar to wt GRK2 (Figure S4A), with t
of 1.3 ± 0.4 s, n = 6 and 1.3 ± 0.3 s, n = 20, respectively.
GRK2D97-140, a GRK2 mutant that lacks the two helices that
are involved in GRK2-Gaq interaction, was also able enhance
GCD with t of 3.2 ± 0.8 s; n = 8. These results indicate thatCell 143, 750–760, November 24, 2010 ª2010 Elsevier Inc. 753
BA
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Figure 4. GRK2Mutantswith ImpairedGbgBindingCapability Fail to
Accelerate GIRK Desensitization
(A) A cartoon that displays the structure of the complex of GRK2 with Gbg
(Tesmer et al., 2005). The locations of the different point-mutations that were
used in (B) are marked in red.
(B) A bar plot summarizing the desensitization rates (t, s) of GIRK currents,
measured from cells transfected with GIRK channel, A1R, and the various
GRK2 mutants.
(C) A bar plot comparing the effect of myristoylated GRK2 (myr-GRK2) and
myrGRK2/R587Q mutant on GIRK desensitization rate.
See also Figure S4.GRK2 interaction with Gaq is not required for GRK2 action on
GIRK currents.
The interactions between GRK2 and Gbg or phosphatidylino-
sitol 4,5-bisphosphate (PtdIns(4,5)P2) have also been thoroughly
studied in vitro, with different point mutations in GRK2
PH-domain (Carman et al., 2000; Sterne-Marr et al., 2003;
Touhara et al., 1995). Because both Gbg and PtdIns(4,5)P2 are
key players in the activation of GIRK channels (Huang et al.,
1998; Logothetis et al., 1987; Reuveny et al., 1994; Sui et al.,
1998), the GRK2-mediated enhancement of GCD might involve
interference of the interactions with these two molecules. We
thus comparedGCD rates of control andGRK2 transfected cells,
and compared them with cells coexpressing the various GRK2
mutants (Figure 4A): GRK2/R587Q (Carman et al., 2000) and
GRK2/K663E;K665E;K667E (Touhara et al., 1995), that disrupt
the interactions of the kinase with Gbg, and GRK2/754 Cell 143, 750–760, November 24, 2010 ª2010 Elsevier Inc.K567E;R578E mutant that disrupts GRK2-PtdIns(4,5)P2 interac-
tions. Disrupting GRK2 interactions with Gbg abolished the
GRK2-mediated enhancement of GCD with t of 15.6 ± 1.9 s,
n = 32 and 12.6 ± 1.8 s, n = 15 for the GRK2/R587Q and
GRK2/K663E;K665E;K667E, respectively (Figure 4B). These
rates are comparable with cells that do not coexpress GRK2,
(t of 19.3 ± 2.1 s, n = 37). Furthermore, mutations that interrupt
GRK2 interactions with PtdIns(4,5)P2, GRK2/K567E;R578E
partially reduced the enhancement of GCD with t of 5.8 ±
0.6 s, n = 13. When the ability of membrane translocation after
receptor activation was tested for both PtdIns(4,5)P2 and Gbg
interaction mutants, using GRK2/K567E;R578E-GFP, GRK2/
K663E;K665E;K667E-GFP or GRK2/R587Q-GFP, respectively,
translocations to the membrane could be seen, but were
reduced in comparison to the wt GRK2 (Figure S4B). On the
contrary, a triple mutant GRK2/K567E;R578E;R587Q-GFP, in
whichmutations that disrupt bothGbg and PtdIns(4,5)P2 binding
were introduced, no translocations were observed (Figure S4B).
These results are in agreement with the observations of coordi-
nated interactions of GRK2 with Gbg and PtdIns(4,5)P2 in
mediating GRK2 membrane recruitment (Pitcher et al., 1995).
To address whether the inability of GRK2/R587Q to accelerate
GCD is due to its reduced membrane translocation, we tethered
wild-type GRK2-GFP and GRK2/R587Q-GFP to the membrane
by fusing them with Src-myristoylation signal (myrGRK2-GFP
andmyrGRK2/R587Q-GFP, respectively) (Figure 4C). GCD rates
were 1.3 ± 0.5 s (n = 8) and 23.9 ± 5.4 s (n = 5), for myrGRK2-GFP
and myrGRK2/R587Q-GFP, respectively (p < 0.05). Moreover,
five cells expressing myrGRK2/R587Q-GFP did not display
GCD at all. This supports the idea that failure of myrGRK2/
R587Q to accelerate GCD is due to its inability to chelate Gbg,
and not due to its impaired membrane targeting.
GRK2 Does Not Cause Desensitization
of Constituently Active GIRK Mutants
Because Gbg-GRK2 interactions seem to play an important role
in mediating the enhancement of GCD, one possible scenario is
that GRK2 is competing with the GIRK channel for Gbg on A1R-
activated release. To test this possibility, we examined the effect
of GRK on constituently active, Gbg independent GIRK mutant
channels (Sadja et al., 2001), GIRK1/S170P;GIRK4/S176P (Fig-
ure 5A). To avoid saturation and to ensure high quality voltage
clamp, we recorded currents in 5.6 mM external K+ solution.
Whole cell recordings of GIRK1/S170P;GIRK4/S176P show
high basal activity regardless of receptor activation (Figure S5)
(Sadja et al., 2001), with only a minor current induction on aden-
osine application. In contrast to wt GIRK recordings, GRK2 failed
to accelerate the GCD rates of the mutant channels (Figure 5B).
Currents flowing through GIRK1/S170P;GIRK4/S176P channel
mutants without or with GRK2 cotransfection showed current
levels of 95 ± 2%, n = 8 and 81 ± 4%, n = 10 (at 5 s of agonist
application), respectively. This is in contrast to the significant
GCD observed for the wild-type channel that had a reduction
of the residual current from 94 ± 14%, n = 7 to only 21 ± 4%,
n = 10 with GRK2 cotransfection at the same time point
(Figure 5B). These findings further point toward the possibility
that GRK2-mediated GCD involves the competition between
the channel and GRK2 for Gbg subunit.
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Figure 5. Constituently Active, Gbg-Inde-
pendent, but Not GIRK Mutants that Have
Higher Affinity to PtdIns(4,5)P2, Are Insensi-
tive to GRK2
(A) Typical traces of GIRK1/S170P;GIRK4/S176P
channel mutants, without (upper trace) or in the
presence of GRK2 (lower trace).
(B) A bar plot summarizing the residual current
(in % of total current) after agonist application
without (dark gray) and in the presence of GRK2
(light gray).
(C) Typical current traces of GIRK1/M223L;GIRK4/
I229L channel mutants, without (upper trace) or in
the presence of GRK2 (lower trace).
(D) A bar plot summarizing the residual current (in
% of induced current) after agonist application
from cell without (dark gray) and with GRK2
(light gray). In both case, desensitization was
measure 5 s after agonist application.
See also Figure S5.In light of the results described above, we were interested to
test whether PtdIns(4,5)P2 depletion from the channel may also
account for GRK2-mediated GCD. Therefore, we took an
advantage of the previously described GIRK mutants that
display enhanced PtdIns(4,5)P2 affinity, GIRK1/M223L;GIRK4/
I229L (Koike-Tani et al., 2005; Zhang et al., 1999) (Figure 5C).
Increasing GIRK channel affinity to PtdIns(4,5)P2 did not inhibit
the action of GRK2 on GCD rates, where GIRK1/M223L;
GIRK4/I229L without or with GRK2 showed (at 5 s during agonist
application) residual currents of 75 ± 4%, n = 13 and 31 ± 7%,
n = 16, respectively. Wild-type GIRK without or with GRK2
showed residual currents of 88 ± 5%, n = 7 and 14 ± 4%, n = 10,
respectively (Figure 5D). These results demonstrate that
GRK2-mediated acceleration of GCD does not occur by PtdIns
(4,5)P2 depletion from the channel.
A1R Activation Increases the Fraction of GRK2-Bound
Gbg Population
As shown above, mutations that impair GRK2-Gbg interaction
abolish the ability of GRK2 to accelerate GCD. To obtain further
evidence that indeed GRK2 binds Gbg in the context of the
plasma membrane, we recorded dynamic FRET using fluores-
cence lifetime approach (FRET-FLIM), under TIRF microscopy.
In this method donor fluorescence lifetime is recorded continu-
ously and shortening in donor lifetime is indicative of FRET. For
this purpose we used YFP and mCherry as donor and acceptor,
respectively. This pair has the advantage of a significant overlap
between donor emission and acceptor absorption, yet leaving an
acceptor-free donor fluorescence bandwidth for detection,
resulting in high FRET efficiencies (Goedhart et al., 2007) (Fig-
ure S6A). YFP has a nearly monoexponential lifetime decay
(Figures S6A and S6B) (Kremers et al., 2006), making it suitable
for use as a donor for FLIM measurements. Although cytosolicCell 143, 750–760, NYFP showed a t of 2.6 ± 0.0 ns, n = 10,
in a fused dimer of YFP and mCherry
a subpopulation (92.9 ± 0.5%) of the
donor molecules displayed a muchshorter lifetime (0.6 ± 0.0 ns) corresponding to a FRET efficiency
of 76.7 ± 0.2%, n = 10 (Figure S6A). We set out to measure the
changes in FRET between N-terminally fused Gb1 with YFP
(YFP-Gb1) (Riven et al., 2006) and C-terminally fused GRK2
with mCherry (GRK2-Cherry) (Figure 6A). On A1R activation
YFP-Gb1 fluorescence decreased in the presence of GRK2-
Cherry, in agreement with YFP fluorescence quenching by
mCherry due to FRET (Figure 6B). Fitting the fluorescence life-
time decays of the donor over time revealed that, at rest, two
donor subpopulations exist (Figure 6C). One subpopulation
(22.6 ± 0.9%, n = 8) contains YFP-Gb1 proteins that interact
with GRK2-Cherry and hence result in shorter fluorescent life-
times of 0.6 ± 0.1 ns, n = 8. The remaining fraction consists of
free YFP-Gb1 proteins that display the characteristic monoexpo-
nential lifetime of YFP-Gb1 monomers (t-3.04 ns; see Fig-
ure S6B). After A1R activation, the relative fraction of YFP-Gb1
subunits that interact with GRK2-Cherry increases, seen as an
increase in the relative fraction of the shorter lifetime constants
(to 29.4 ± 1.6%, n = 8, p < 0.05) and as a decrease in the fraction
displaying long lifetime of the YFP (Figure 6C, D). The time
course of the shift in relative fraction of short and long lifetimes
(4.2 ± 0.7 s) resembles GCD rates and GRK2 translocations.
Similar correlation was seen when mOR was used, the rates of
YFP-Gb1 association with GRK2-Cherry was similar to the
GCD and to the GRK2-GFP translocation rates, with t average
for binding increase of 69.5 ± 15.3 s (n = 6) (Figure S6C). These
findings support the above observations that GRK2 action on
GCD is mediated through the binding of Gbg to GRK2.
DISCUSSION
Desensitization is an important cellular mechanism that allows
cells to adapt to long-term external stimuli. In the case ofovember 24, 2010 ª2010 Elsevier Inc. 755
20
30
40
50
60
70
80
0 50 100 150 200 250 300
R
el
at
ive
 fr
ac
tio
n 
(%
)
Time (s)
Tau donor
Tau fret
Ade
Ade
C
BA
-40
-20
0
20
40
60
80
100
120
0 20 40 60 80
In
cr
ea
se
 b
in
di
ng
 (N
orm
ali
ze
d, 
%)
Time (s)
D
Ade
600
650
700
750
800
850
900
950
1000
0 50 100 150 200 250 300
Co
un
ts
 
Time (s)
Figure 6. FLIM-FRET under TIRF Reveals
that A1R Activation Increases the Fraction
of GRK2-Bound Gbg
(A) A cartoon showing the experimental scheme
used in the FLIM-FRET experiments.
(B) Time course of YFP-Gb1 emission after the
activation of A1R in the presence of GRK2-Cherry,
in agreement with YFP quenching by mCherry on
increase of FRET.
(C) YFP-Gb1 lifetime changes after A1R activation.
Yellow symbol depicts the FRET-free YFP-Gb1
(t of 3.0 ns fraction) and red symbol depicts the
faster lifetime component (0.9 ns) that corre-
sponds to a FRET interaction between YFP-Gb1
and GRK2-Cherry. This FRET interaction corre-
sponds to a FRET efficiency of 0.7.
(D) YFP-Gb1 GRK2-Cherry binding increases
after A1R activation (n = 9). Black line depicts
the fitting to a monoexponential function with a
t = 4.2 ± 0.7 s.
See also Figure S6.GPCR signaling pathways, desensitization is mediated by a
decrease in the cellular response to a continuous GPCR stimula-
tion by agonists, resulting in a decrease in receptor number at
the plasma membrane. This process, that takes minutes to
hours, is mediated by phosphorylation of the receptor by GRK,
leading to clathrin-mediated endocytosis, in a process termed
downregulation (Bunemann et al., 1999; Tsao and von Zastrow,
2000). In addition to this well characterized process, other
mechanisms are necessary for a more rapid control of GPCR-
mediated signaling, specifically when the signal is intended to
control changes in electrical responsiveness of cells. In this
study we have described a mechanism that is responsible for
the termination of GPCR-mediated activation of GIRK channels,
which occurs within seconds.
In locus ceruleus neurons, Blanchet and Luscher (2002)
showed that prolonged activation of the mOR leads to inhibition
of GIRK function. It was shown that whereas mOR-mediated
presynaptic inhibition remained constant over time, postsyn-
aptic inhibition, mediated by GIRK activation, showed strong
desensitization of the response, indicating control over the
GIRK currents downstream of the receptors. This decrease in
GIRK currents could be overcome by additional activation of
G protein pathways. As a possible model for their results, it
was suggested that the receptor might activate Gbg scaven-
gers such as GRK2 and GRK3, to induce competitive inhibition
on GIRK activation. In a separate study using the same
neurons, it was shown that GCD was dependent on two molec-
ular pathways, the b-arrestin/GRK2 and the ERK1/2 pathways
(Dang et al., 2009). These findings suggested that GCD might
involve modifications of the G protein pathway that serves to
translate receptor activation to GIRK gating. In contrast, GCD
by muscarinic receptor stimulation has been attributed to
a mechanism solely involved the GPCR phosphorylation-
dependent and independent mechanisms by GRK2, and not756 Cell 143, 750–760, November 24, 2010 ª2010 Elsevier Inc.the G protein subunits (Shui et al., 1998). Here, using electro-
physiological and fluorescence resonance energy transfer
techniques, we unequivocally demonstrate that GRK2 is the
component of the G protein pathway that mediates this
short-term current decrease in the presence of the receptor
agonist. The molecular mechanism of this action will be
discussed below.
Based on our results, we suggest the following mechanism for
GRK2-mediated GCD (Figure 7): at rest, trimeric G-proteins are
bound to the nonactivated Gi/o-coupled GPCR and the channel
(Riven et al., 2006). After receptor activation by an agonist, the
Gbg subunits dissociate from the Ga subunit to interact with
the Gbg-binding domains on the channel, and promote channel
gating (opening). At the same time, GRK2 is recruited, either
within the two-dimensional space of the membrane (within
100 nm of the membrane space), or through the classical
cytosolic-to-plasma membrane translocation (Pitcher et al.,
1998). The former possibility may be aided by PtdIns(4,5)P2 or
by other membrane associated proteins, including the GIRK1
channel subunit (Dhami et al., 2004; Li et al., 2003; Palczewski,
1997; Rishal et al., 2005). This recruitment of GRK2, which is in
our case a receptor-specific event, promotes the binding of
the Gbg subunit to GRK2 or GRK3, but not GRK6 that lacks
Gbg binding capability, and thus reduces the availability of the
Gbg subunits to the channel. To have this chelation capacity,
GRK2 has to have a higher or comparable affinity for Gbg than
does the channel. Indeed, from binding studies it has been
shown that Gbg subunits bind recombinant GIRK1 or GIRK4
subunits with dissociation constants of 125 nM and 50 nM,
respectively (Krapivinsky et al., 1995), whereas Gbg affinity for
GRK2 is 20 nM (Pitcher et al., 1992; Wu et al., 1998). Further
evidence to support the idea that differential affinity to Gbg
may mediate this action comes from experiments where
GIRK4 was overexpressed in atrial myocytes (Bender et al.,
Figure 7. A Cartoon Describing the Mechanism by
Which GRK2 Is Negatively Regulating GIRK Channel
Function
On receptor stimulation by GPCR, the G protein trimer
undergoes activation characterized by the exchange of GDP
for GTP on theGa subunit. This in turn leads to the dissociation
of the Gbg subunits to freely bind and activate the GIRK
channel. Concomitantly, the GPCR induces the recruitment
of GRK2 to the plasma membrane making it available to bind
Gbg subunits of the G protein. Due to the relative higher affinity
of GRK2 for Gbg and to the larger mass action, GRK2 is now
able to effectively compete for the available pool of Gbg with
the GIRK channel, leading to a gradual removal of the Gbg
subunits and to a channel closure (desensitization), still in the
presence of the receptor agonist. Channel activation precedes
the action of GRK2 mainly due to the preexisting trimeric G
proteins in the vicinity of the channels (Riven et al., 2006).2001). In these experiments, GCD rates were greatly reduced, in
comparison to the GCD of GIRK1/4 heterotetramer, supporting
the idea that high affinity binding of Gbg may determine the
extent of channel current desensitization. Removal of Gbg from
the channel by GRK to affect channel function may not require
the removal of all four Gbg subunits, due to the steep depen-
dence of channel function on Gbg binding (Sadja et al., 2002).
Removing only one Gbg dimer reduces the efficacy of gating
by 70%. Finally, by using other means to chelate Gbg on the
membrane, such as coexpression of phosducin, similar effects
on GCD can be achieved (Riven et al., 2006). In conclusion, the
evidence provided above strongly points toward the possibility
that the acceleration of GCD by GRK2 is due to competition
for Gbg dimers with the channel.
How may GRK2-mediated GCD be interpreted in light of
previous suggested mechanisms? Few other mechanisms
have been proposed in the past to explain GCD. It has been
proposed that GIRK desensitization in cardiac cells might result
from simultaneous activation of M2R and M3R of the Gi/o and
the Gq pathways by acetylcholine, respectively (Keselman
et al., 2007; Kobrinsky et al., 2000; Meyer et al., 2001). Whereas
the former leads to GIRK opening, the latter leads to GCD by
PLC-mediated PtdIns(4,5)P2 depletion. Evidently, GCD occurs
also in simpler cases, where cross-talk between different GPCRs
pathways are probably not involved, and can be independent of
PtdIns(4,5)P2 depletion as showed by the use of PLC inhibitors
or activators (Meyer et al., 2001; Sickmann and Alzheimer,
2003). This was also true for our observations using NCDC,
a PLC inhibitor that does not block GIRK channel function (Sick-
mann et al., 2008). Furthermore, as shown above, mutations that
affect the affinity of the channel to PtdIns(4,5)P2 (Koike-Tani
et al., 2005; Zhang et al., 1999), are not affecting GRK2-mediated
channel desensitization. We thus suggest that changes in PtdIns
(4,5)P2 may only be an additional form of a much slower regula-
tion of channel function, mediated by the enzymatic activity of
PLC (Kobrinsky et al., 2000).
Our observations show that among four different receptors
described in this study, GCD was tightly regulated by GRK2 in
currents induced by A1R and mOR, showing a very robust
acceleration of GCD. On the contrary two other receptors,
namely mGluR2 and M4R were not able to induce GCD in the
presence of GRK2. How might this receptor selectivity beaddressed? It is interesting to note that receptors that were not
able to support GRK2-mediated GCD, were also not able to
recruit GRK2 to the plasma membrane, even though they all
release Gbg on activation to gate GIRK channels. This may
suggest that different receptors have differential mechanisms
to recruit GRK2 to the plasma membrane. The process of
membrane recruitment of GRK proteins has been ascribed to
a Gbg subunit-dependent mechanism (Pitcher et al., 1998;
Pitcher et al., 1992). It is therefore not clear how only a subset
of receptors have the ability to recruit the kinase, where others,
that also release Gbg to activate the GIRK channels, do not.
We have tried to address this issue and found that neither PLC
inhibition by NCDC, treatment with pertussis toxin, or using
dominant negative Gas mutant (Berlot, 2002) affected the ability
of the receptor to recruit GRK2 to the membrane (see Figure S3).
This may suggest of other still unknown mechanisms that
mediate this process by selective type of GPCRs, probably by
a specific direct interaction of the intracellular loops of the
receptor with GRK2.
How might the immediate desensitization be achieved? In
addition to cytosolic GRK that is recruited to the membrane on
receptor activation, a basal membranous subpopulation of
GRK2 is observed by us and by others (Aragay et al., 1998;
Garcia-Higuera et al., 1994; Murga et al., 1998). This subpopula-
tion can enable the immediate negative feedback of GIRK
activation. We cannot rule out also the possibility that GRK is
precoupled to GIRK (Rishal et al., 2005) and undergoes an
orientation/conformation change on activation, enabling its
immediate competition with the channels for Gbg subunits.
There are many studies suggesting the existence of signaling
complex between GIRK and Gbg (Clancy et al., 2005; Doupnik,
2008; Nikolov and Ivanova-Nikolova, 2004; Riven et al., 2006).
The GIRK-Gbg precoupling, before GPCR activation, might
enable the specificity of GPCR signaling cascade in an environ-
ment that may be populated by receptors of different types. Gbg
precoupled to GIRK undergo local rearrangement on GPCR
activation to immediately transduce GIRK gating independent
of diffusion rates (Riven et al., 2006). So if indeed the effector
(GIRK) is a module precoupled to its ‘‘switch-on,’’ could it be
that it is also precoupled to its ‘‘switch-off’’? There is evidence
that GRK2 and GIRK channel encompass a common signaling
complex (Nikolov and Ivanova-Nikolova, 2004).Cell 143, 750–760, November 24, 2010 ª2010 Elsevier Inc. 757
Our results add a unique aspect to emerging evidence for
phosphorylation-independent activity of the GRK family, from
the regulation of receptor numbers or uncoupling of the GPCR
from the G protein at the plasma membrane, to regulation of
intracellular enzymes (for reviews see Ferguson [2007] andReiter
and Lefkowitz [2006]). In all of these cases, there is no indication
of a direct involvement of the Gbg subunits of the G protein in
GRK action. GPCR/GRK2-dependent action on channel activity,
or other effectors, forms a new mechanism for a short-term
negative feedback for GPCR function, that selectively regulate
effector activity in the continued presence of receptor agonists.
This mechanism may not exclusively pertain to GIRK channels,
but can be relevant to all membrane associated Gbg regulated
effectors (Dupre et al., 2009). Because drug therapies for many
diseases are targeted to the receptor, a better understanding
of the pathway that links receptor to effector activation and
regulation (in this case the GIRK channel), and finding new
means to regulate these steps, might lead to therapies with
better resistance to complications such as tolerance and
side-effects.
EXPERIMENTAL PROCEDURES
Patch-Clamp Recordings
Membrane currents were recorded under voltage-clamp conditions using
whole-cell patch-clamp configuration with an Axopatch 200B (Axon Instru-
ments) patch-clamp amplifier. Patch pipettes were fabricated from borosili-
cate glass capillaries (2–5 MU). Signals were analog filtered using a 1 kHz
low-pass Bessel filter. After patch formation in a low K+ bath solution, the
bath solution was changed to high K+ solution. Adenosine (100 mM), glutamate
(100 mM), methionine enkephalin (ME, 100 nM), carbachol (100 mM), and Ba+2
(3 mM) were used to study induced and basal GIRK currents. GIRK currents
were measured as inward currents at a holding potential of 80 mV at room
temperature. Data acquisition and analysis were done using pCLAMP 9
software (Axon Instruments). To determine GCD kinetics, current traces
were fitted to a monoexponential decay function using Chebyshev method.
Results are expressed as average ± standard error of the mean (SEM). Signif-
icant differences were considered when p < 0.05 using Student’s t test.
TIRF Microscopy
Fluorescence was measured using through the objective TIRF microscopy
(Riven et al., 2003) with a 60 3 1.45 N.A. TIRFM objective (Olympus, Japan)
and TIRF condenser (TILL Photonics, Germany). Images were acquired with
Ixon+ EMCCD camera (Andor, Ireland) using Imaging Workbench 6 software
(Indec, USA). DF/F (%) was calculated from ROI that contained the whole
cell membrane area and was background subtracted. Time constant (t) for
GRK2 translocations, was calculated by determining the time after agonist
application when fluorescence reached 63% of maximum.
Fluorescence Lifetime Measurements
For fluorescence lifetime measurements (FLIM), 470 nm ps diode laser
(FWHM < 90 ps) was used, driven by a 40 MHz pulse controller, PDL 800-B.
Single photons were collected using PMA-165P photon counter and
processed using TimeHarp 200 PC-board. Data was acquired and analyzed
using SymPhoTime software (PicoQuant, Germany). Donor fluorescence
was collected from single cells under TIRF configuration (Riven et al., 2003).
For all measurements, laser intensities were set such that signal count rate
will be <1% of laser pulse rate. IRF was reconstructed from lifetime measure-
ment of YFP-Gb1 under TIRF using laser powers comparable to those used in
the experiment. YFP-Gb1 monomer lifetime was monoexponential with t of
3.0 ns (Figure S6B). To extract lifetimes and relative intensities, donor fluores-
cence traces were binned to 1-s segments and IRF reconvoluted trace
was fitted to double-exponential fitting model. One t parameter, td, was758 Cell 143, 750–760, November 24, 2010 ª2010 Elsevier Inc.constrained to 3.0 ns (YFP-Gb1), and tda as well as the relative size for
each exponential term was extracted from fitting result (Lleres et al., 2007;
Peter et al., 2005; Wallrabe and Periasamy, 2005; Yasuda et al., 2006).
Maximum likelihood estimation (MLE) method was used for fitting. Fit quality
was examined both by c2 values and by the absence of systematic variations
of fit residuals.
Molecular Biology and Cell Culture
Fusions to fluorescent proteins (EGFP, YFP and mCherry) were based on
commercially available pCMV-XFP vectors (Clontech). In EGFP A206K point
mutation was made to eliminate its week dimerization tendency (Zacharias
et al., 2002). Point mutations and deletion done in GIRK and GRK2 were
carried out by polymerase chain reaction (PCR) and verified by sequencing.
Nonfused GIRK and PTX-S1 subunits (Sadja and Reuveny, 2009) were all in
pcDNA3.1 (Invitrogen). C-terminal fusion of fluorescent proteins to GRK2 did
not affect its function. HEK293 cells were transiently transfected using
Metafectene (Biontex, Germany) with cDNAs encoding for the channel
subunits, the receptor of choice and GRK (wt, GFP-fused or mutant). In
GRK2 silencing experiments GRK2 shRNA (0.1 mg) or nontarget control
(0.1 mg) was cotransfected with the channel and the receptor. Currents were
measured 24–48 hr posttransfection according to Raveh et al. (2008). The
HL-1 cells, a gift from Dr. William C. Claycomb, were maintained using the
recommended protocols (Claycomb et al., 1998). For electrophysiology
experiments, cells were transferred to uncoated 24-mm glass coverslips on
the day of the recording.
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